Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 2
2007 2
2008 1
2009 3
2010 6
2011 6
2012 3
2013 1
2014 14
2015 21
2016 15
2017 14
2018 7
2019 20
2020 18
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X, Sun S, Sun Y, Song Q, Zhu J, Song N, Chen M, Sun T, Xia M, Ding J, Lu M, Yao H, Hu G. Han X, et al. Among authors: Sun S, Sun Y, Sun T. Autophagy. 2019 Nov;15(11):1860-1881. doi: 10.1080/15548627.2019.1596481. Epub 2019 Apr 9. Autophagy. 2019. PMID: 30966861 Free PMC article.
MethHC: a database of DNA methylation and gene expression in human cancer.
Huang WY, Hsu SD, Huang HY, Sun YM, Chou CH, Weng SL, Huang HD. Huang WY, et al. Among authors: Sun YM. Nucleic Acids Res. 2015 Jan;43(Database issue):D856-61. doi: 10.1093/nar/gku1151. Epub 2014 Nov 14. Nucleic Acids Res. 2015. PMID: 25398901 Free PMC article.
Swiprosin-1 deficiency impairs macrophage immune response of septic mice.
Zhang S, Tu Y, Sun YM, Li Y, Wang RM, Cao Y, Li L, Zhang LC, Wang ZB. Zhang S, et al. Among authors: Sun YM. JCI Insight. 2018 Feb 8;3(3):e95396. doi: 10.1172/jci.insight.95396. eCollection 2018 Feb 8. JCI Insight. 2018. PMID: 29415882 Free PMC article.
Discovery of JND3229 as a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy.
Lu X, Zhang T, Zhu SJ, Xun Q, Tong L, Hu X, Li Y, Chan S, Su Y, Sun Y, Chen Y, Ding J, Yun CH, Xie H, Ding K. Lu X, et al. Among authors: Sun Y. ACS Med Chem Lett. 2018 Oct 8;9(11):1123-1127. doi: 10.1021/acsmedchemlett.8b00373. eCollection 2018 Nov 8. ACS Med Chem Lett. 2018. PMID: 30429956 Free PMC article.
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice.
Pan Q, Sun Y, Jin Q, Li Q, Wang Q, Liu H, Zhao S. Pan Q, et al. Among authors: Sun Y. Acta Cir Bras. 2016 Nov;31(11):724-729. doi: 10.1590/S0102-865020160110000004. Acta Cir Bras. 2016. PMID: 27982259 Free article.
Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer.
Liu XL, Xu YC, Wang YX, Chen Y, Wang BB, Wang Y, Chen YH, Tan C, Hu LD, Ma QY, Zhang YC, Sun YM, Gao YL, Yang CH, Ding J, Meng LH. Liu XL, et al. Among authors: Sun YM. Cancer Lett. 2018 Oct 1;433:273-282. doi: 10.1016/j.canlet.2018.07.011. Epub 2018 Jul 9. Cancer Lett. 2018. PMID: 30003928
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models.
Ai J, Chen Y, Peng X, Ji Y, Xi Y, Shen Y, Yang X, Su Y, Sun Y, Gao Y, Ma Y, Xiong B, Shen J, Ding J, Geng M. Ai J, et al. Among authors: Sun Y. Mol Cancer Ther. 2018 Apr;17(4):751-762. doi: 10.1158/1535-7163.MCT-17-0368. Epub 2017 Dec 13. Mol Cancer Ther. 2018. PMID: 29237805 Free article.
121 results
Jump to page
Feedback